Tirzepatide (60 mg)
Also known as: Tirzepatide, LY3298176
Molecular Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide used in metabolic research to study combined incretin-receptor pharmacology. This entry corresponds to the higher-quantity catalog item.
Mechanistic Background
Co-agonism at GIP and GLP-1 receptors activates incretin signalling pathways.
What Researchers Study
Research has examined GIP/GLP-1 receptor pharmacology and metabolic endpoints.
Evidence Landscape
Current evidence level: EARLY TRANSLATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
Educational reference only; not a treatment recommendation.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.